BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu VC, Wang SM, Chang CH, Hu YH, Lin LY, Lin YH, Chueh SC, Chen L, Wu KD. Long term outcome of Aldosteronism after target treatments. Sci Rep 2016;6:32103. [PMID: 27586402 DOI: 10.1038/srep32103] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Vaidya A, Carey RM. Evolution of the Primary Aldosteronism Syndrome: Updating the Approach. J Clin Endocrinol Metab 2020;105:dgaa606. [PMID: 32865201 DOI: 10.1210/clinem/dgaa606] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
2 Luo Q, Li N, Wang M, Yao X, Heizhati M, Zhang D, Zhou K, Wang G, Hu J, Zhu B. Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study. J Hum Hypertens 2020;34:633-40. [PMID: 31792441 DOI: 10.1038/s41371-019-0291-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pan CT, Liao CW, Tsai CH, Chen ZW, Chen L, Hung CS, Liu YC, Lin PC, Chang CC, Chang YY, Wu VC, Lin YH; TAIPAI study group †. Influence of Different Treatment Strategies on New-Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort-Based Study. J Am Heart Assoc 2020;9:e013699. [PMID: 32070205 DOI: 10.1161/JAHA.119.013699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Chen ZW, Huang KC, Lee JK, Lin LC, Chen CW, Chang YY, Liao CW, Wu VC, Hung CS, Lin YH; TAIPAI study group. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study. J Hypertens 2018;36:353-60. [PMID: 28902663 DOI: 10.1097/HJH.0000000000001534] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
5 Wierdak M, Sokołowski G, Natkaniec M, Morawiec-Sławek K, Małczak P, Major P, Hubalewska-Dydejczyk A, Budzyński A, Pędziwiatr M. Short- and long-term results of laparoscopic adrenalectomy for Conn's syndrome. Wideochir Inne Tech Maloinwazyjne 2018;13:292-8. [PMID: 30302141 DOI: 10.5114/wiitm.2018.74833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Stavropoulos K, Papadopoulos C, Koutsampasopoulos K, Lales G, Mitas C, Doumas M. Mineralocorticoid Receptor Antagonists in Primary Aldosteronism. CPD 2019;24:5508-16. [DOI: 10.2174/1381612825666190311130138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Chen CW, Tsai CH, Hung CS, Tsai IJ, Chiu YW, Chang CC, Liu KL, Liao SC, Wu VC, Lin YH. Comparison of cystatin C-based and creatinine-based glomerular filtration rate in the prediction of postoperative residual hypertension in aldosterone-producing adenoma patients after adrenalectomy. Clin Chim Acta 2021;520:147-53. [PMID: 34116005 DOI: 10.1016/j.cca.2021.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chang CH, Chueh SJ, Wu VC, Chen L, Lin YH, Hu YH, Wu KD, Tsai YC. Risk of severe erectile dysfunction in primary hyperaldosteronism: A population-based propensity score matching cohort study. Surgery 2019;165:622-8. [PMID: 30473204 DOI: 10.1016/j.surg.2018.08.020] [Reference Citation Analysis]
9 Wu VC, Chueh JS, Hsieh MY, Hu YH, Huang KH, Lin YH, Yang SY, Chu TS, Kuo CF. Familial Aggregation and Heritability of Aldosteronism with Cardiovascular Events. J Clin Endocrinol Metab 2020;105:dgz257. [PMID: 32193536 DOI: 10.1210/clinem/dgz257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Sivarajah M, Beninato T, Fahey TJ 3rd. Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system. Surgery 2020;167:211-5. [PMID: 31564486 DOI: 10.1016/j.surg.2019.05.087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Chen ZW, Tsai CH, Pan CT, Chou CH, Liao CW, Hung CS, Wu VC, Lin YH; TAIPAI Study Group. Endothelial Dysfunction in Primary Aldosteronism. Int J Mol Sci 2019;20:E5214. [PMID: 31640178 DOI: 10.3390/ijms20205214] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
12 Chauhan K, Schachna E, Libianto R, Ryan J, Hutton H, Fuller PJ, Wilson S, Kerr PG, Yang J. Screening for primary aldosteronism is underutilised in patients with chronic kidney disease. J Nephrol 2022. [PMID: 35195879 DOI: 10.1007/s40620-022-01267-3] [Reference Citation Analysis]
13 Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V. Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans : A Retrospective Cohort Study. Ann Intern Med 2021;174:289-97. [PMID: 33370170 DOI: 10.7326/M20-4873] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
14 Rossi GP, Ceolotto G, Rossitto G, Maiolino G, Cesari M, Seccia TM. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study. J Clin Endocrinol Metab 2020;105:dgaa080. [PMID: 32067030 DOI: 10.1210/clinem/dgaa080] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
15 Satoh M, Maruhashi T, Yoshida Y, Shibata H. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism. Hypertens Res 2019;42:817-24. [PMID: 30948836 DOI: 10.1038/s41440-019-0244-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
16 Hundemer GL, Vaidya A. Primary Aldosteronism Diagnosis and Management: A Clinical Approach. Endocrinol Metab Clin North Am 2019;48:681-700. [PMID: 31655770 DOI: 10.1016/j.ecl.2019.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wu C, Wu V, Yang Y, Lin Y, Yang S, Lin P, Chang C, Tsai Y, Wang S, Wu V, Wu C, Hu Y, Kiaw L, Chang C, Chang Y, Tsai Y, Yu C, Lin Y, Chan C, Lin J, Wang W, Ho Y, Chang H, Lin L, Hu F, Chang C, Liu K, Wang S, Huang K, Jeff Chueh S, Liao S, Lu C, Yen R, Wu K; TAIPAI group. Plasma Aldosterone After Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary Aldosteronism. American Journal of Hypertension 2019;32:1066-74. [DOI: 10.1093/ajh/hpz098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Ahmed S, Hundemer GL. Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism. Front Endocrinol 2022;13:861581. [DOI: 10.3389/fendo.2022.861581] [Reference Citation Analysis]
19 Chan CK, Hu YH, Chen L, Chang CC, Lin YF, Lai TS, Huang KH, Lin YH, Wu VC, Wu KD; TAIPAI Study Group. Risk of sepsis in patients with primary aldosteronism. Crit Care 2018;22:313. [PMID: 30463626 DOI: 10.1186/s13054-018-2239-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Rossi GP, Maiolino G, Flego A, Belfiore A, Bernini G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Muiesan ML, Mannelli M, Negro A, Palumbo G, Parenti G, Rossi E, Mantero F; PAPY Study Investigators. Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term. Hypertension 2018;71:585-91. [PMID: 29483224 DOI: 10.1161/HYPERTENSIONAHA.117.10596] [Cited by in Crossref: 82] [Cited by in F6Publishing: 27] [Article Influence: 20.5] [Reference Citation Analysis]
21 Hundemer GL. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment. Curr Cardiol Rep 2019;21:93. [PMID: 31352525 DOI: 10.1007/s11886-019-1185-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Rossi E, Perazzoli F, Negro A, Magnani A. Diagnostic rate of primary aldosteronism in Emilia-Romagna, Northern Italy, during 16 years (2000–2015). Journal of Hypertension 2017;35:1691-7. [DOI: 10.1097/hjh.0000000000001384] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Barat M, Cottereau A, Gaujoux S, Tenenbaum F, Sibony M, Bertherat J, Libé R, Gaillard M, Jouinot A, Assié G, Hoeffel C, Soyer P, Dohan A. Adrenal Mass Characterization in the Era of Quantitative Imaging: State of the Art. Cancers 2022;14:569. [DOI: 10.3390/cancers14030569] [Reference Citation Analysis]
24 Kishimoto S, Oki K, Maruhashi T, Kajikawa M, Hashimoto H, Takaeko Y, Harada T, Yamaji T, Han Y, Kihara Y, Chayama K, Goto C, Yusoff FM, Nakashima A, Higashi Y. A Comparison of Adrenalectomy and Eplerenone on Vascular Function in Patients with Aldosterone-producing Adenoma. J Clin Endocrinol Metab 2020;105:dgaa561. [PMID: 32818224 DOI: 10.1210/clinem/dgaa561] [Reference Citation Analysis]
25 Hundemer GL, Vaidya A. MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism. Eur J Endocrinol 2020;183:R185-96. [PMID: 33077688 DOI: 10.1530/EJE-20-0863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Tsai CH, Pan CT, Chang YY, Peng SY, Lee PC, Liao CW, Shun CT, Li PT, Wu VC, Chou CH, Tsai IJ, Hung CS, Lin YH. Aldosterone Excess Induced Mitochondria Decrease and Dysfunction via Mineralocorticoid Receptor and Oxidative Stress In Vitro and In Vivo. Biomedicines 2021;9:946. [PMID: 34440149 DOI: 10.3390/biomedicines9080946] [Reference Citation Analysis]
27 El-Asmar N, Rajpal A, Arafah BM. Primary Hyperaldosteronism: Approach to Diagnosis and Management. Med Clin North Am 2021;105:1065-80. [PMID: 34688415 DOI: 10.1016/j.mcna.2021.06.007] [Reference Citation Analysis]
28 Huang WC, Chen YY, Lin YH, Chueh JS. Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:644260. [PMID: 34079522 DOI: 10.3389/fendo.2021.644260] [Reference Citation Analysis]
29 Chang CH, Hu YH, Huang KH, Lin YH, Tsai YC, Wu CH, Yang SY, Chang CC, Lu CC, Wu KD, Wu VC. Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus. J Clin Med 2018;7:E360. [PMID: 30332741 DOI: 10.3390/jcm7100360] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
30 Tsai CH, Pan CT, Chang YY, Chen ZW, Wu VC, Hung CS, Lin YH. Left ventricular remodeling and dysfunction in primary aldosteronism. J Hum Hypertens 2021;35:131-47. [PMID: 33067554 DOI: 10.1038/s41371-020-00426-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chan C, Lai T, Wu V. Reply. Journal of Hypertension 2017;35:2549-50. [DOI: 10.1097/hjh.0000000000001549] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
32 Wu VC, Hu YH, Er LK, Yen RF, Chang CH, Chang YL, Lu CC, Chang CC, Lin JH, Lin YH, Wang TD, Wang CY, Tu ST, Jeff Chueh SC, Chang CC, Tseng FY, Wu KD; TAIPAI group. Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc 2017;116:993-1005. [PMID: 28735660 DOI: 10.1016/j.jfma.2017.06.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
33 Limberg J, Ullmann TM, Gray KD, Stefanova D, Zarnegar R, Li J, Fahey TJ, Beninato T. Laparoscopic Adrenalectomy Has the Same Operative Risk as Routine Laparoscopic Cholecystectomy. Journal of Surgical Research 2019;241:228-34. [DOI: 10.1016/j.jss.2019.03.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
34 Chan C, Kim J, Chueh E, Chang C, Lin Y, Lai T, Huang K, Lin Y, Wu V. Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy. Surgery 2019;166:362-8. [DOI: 10.1016/j.surg.2019.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
35 Liao HW, Wang SM, Chan CK, Lin YH, Lin PC, Ho CH, Liu YC, Chueh JS, Wu VC. Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism. Ther Adv Chronic Dis 2020;11:2040622320944792. [PMID: 32922714 DOI: 10.1177/2040622320944792] [Reference Citation Analysis]
36 Vaidya A, Mulatero P, Baudrand R, Adler GK. The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment. Endocr Rev 2018;39:1057-88. [PMID: 30124805 DOI: 10.1210/er.2018-00139] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 22.0] [Reference Citation Analysis]
37 Yuan Y, Li N, Liu Y, Wang M, Heizhati M, Zhu Q, Yao X, Luo Q. Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism. Endocrine 2021. [PMID: 34780033 DOI: 10.1007/s12020-021-02920-w] [Reference Citation Analysis]
38 Calhoun DA. Medical Versus Surgical Treatment of Primary Aldosteronism. Hypertension 2018;71:566-8. [PMID: 29483223 DOI: 10.1161/HYPERTENSIONAHA.118.10759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J Jr, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Christian Rump L, Vonend O, Willenberg HS, Fuller PJ, Yang J, Chee NYN, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Dun Wu K, Wu VC, Kratka Z, Barbiero G, Battistel M, Chang CC, Vanderriele PE, Pessina AC. Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling. Hypertension 2019;74:800-8. [PMID: 31476901 DOI: 10.1161/HYPERTENSIONAHA.119.13463] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
40 Baudrand R, Guarda FJ, Fardella C, Hundemer G, Brown J, Williams G, Vaidya A. Continuum of Renin-Independent Aldosteronism in Normotension. Hypertension 2017;69:950-6. [PMID: 28289182 DOI: 10.1161/HYPERTENSIONAHA.116.08952] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 14.0] [Reference Citation Analysis]
41 Trinh B, Hepprich M, Betz MJ, Burkard T, Cavelti-Weder C, Seelig E, Meienberg F, Kratschmar DV, Beuschlein F, Reincke M, Odermatt A, Hall MN, Donath MY, Swierczynska MM. Treatment of Primary Aldosteronism With mTORC1 Inhibitors. J Clin Endocrinol Metab 2019;104:4703-14. [PMID: 31087053 DOI: 10.1210/jc.2019-00563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Chen YY, Lin YH, Huang WC, Chueh E, Chen L, Yang SY, Lin PC, Lin LY, Lin YH, Wu VC, Chu TS, Wu KD. Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism. J Endocr Soc 2019;3:1110-26. [PMID: 31086833 DOI: 10.1210/js.2019-00019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
43 Lee MJ, Sun CY, Lu CC, Chang YS, Pan HC, Lin YH, Wu VC, Chueh JS. Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism. Ther Adv Chronic Dis 2021;12:2040622321990274. [PMID: 33633824 DOI: 10.1177/2040622321990274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Huang KH, Yu CC, Hu YH, Chang CC, Chan CK, Liao SC, Tsai YC, Jeff Chueh SC, Wu VC, Lin YH; TAIPAI, Taiwan Primary Aldosteronism Investigator. Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc 2019;118:72-82. [PMID: 29506889 DOI: 10.1016/j.jfma.2018.01.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
45 Chan CK, Yang WS, Lin YH, Huang KH, Lu CC, Hu YH, Wu VC, Chueh JS, Chu TS, Chen YM. Arterial Stiffness Is Associated with Clinical Outcome and Cardiorenal Injury in Lateralized Primary Aldosteronism. J Clin Endocrinol Metab 2020;105:dgaa566. [PMID: 32835357 DOI: 10.1210/clinem/dgaa566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 Maruhashi T, Amioka M, Kishimoto S, Ikenaga H, Oki K, Ishida M, Kihara Y, Higashi Y. Elevated Plasma Renin Activity Caused by Accelerated-malignant Hypertension in a Patient with Aldosterone-producing Adenoma Complicated with Renal Insufficiency. Intern Med 2019;58:3107-11. [PMID: 31292373 DOI: 10.2169/internalmedicine.2327-18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Wu WC, Wei Q, Wu VC. Editorial: Diagnosis and Treatment of Primary Aldosteronism: from Clinical Origin to Translational Research. Front Endocrinol (Lausanne) 2021;12:781105. [PMID: 34917034 DOI: 10.3389/fendo.2021.781105] [Reference Citation Analysis]
48 Peng KY, Liao HW, Chan CK, Lin WC, Yang SY, Tsai YC, Huang KH, Lin YH, Chueh JS, Wu VC. Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success. Hypertension 2020;76:1537-44. [PMID: 32921192 DOI: 10.1161/HYPERTENSIONAHA.120.15328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
49 Liao HW, Peng KY, Wu VC, Lin YH, Lin SL, Lin WC, Chueh JS, On Behalf Of Taipai Study Group. Characteristics of a Novel ATP2B3 K416_F418delinsN Mutation in a Classical Aldosterone-Producing Adenoma. Cancers (Basel) 2021;13:4729. [PMID: 34572956 DOI: 10.3390/cancers13184729] [Reference Citation Analysis]
50 Torresan F, Rossitto G, Bisogni V, Lerco S, Maiolino G, Cesari M, Zhu R, Iacobone M, Seccia T, Rossi G. Resolution of drug-resistant hypertension by adrenal vein sampling-guided adrenalectomy: a proof-of-concept study. Clinical Science 2020;134:1265-78. [DOI: 10.1042/cs20200340] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Chan CK, Chang YY, Tsai YC, Chen ZW, Wu CY, Huang WC, Yen IW, Wu KH, Wu VC, Lin YH; TAIPAI Study Group. Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection. J Formos Med Assoc 2021:S0929-6646(21)00137-6. [PMID: 33906783 DOI: 10.1016/j.jfma.2021.03.032] [Reference Citation Analysis]
52 Lin JH, Lin YF, Wang WJ, Lin YF, Chueh SJ, Wu VC, Chu TS, Wu KD; Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group. Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease. J Clin Med 2018;7:E382. [PMID: 30355992 DOI: 10.3390/jcm7110382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Sam D, Kline GA, So B, Przybojewski SJ, Leung AA. Unilateral Disease Is Common in Patients With Primary Aldosteronism Without Adrenal Nodules. Can J Cardiol 2021;37:269-75. [PMID: 32428615 DOI: 10.1016/j.cjca.2020.05.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Jaffe G, Gray Z, Krishnan G, Stedman M, Zheng Y, Han J, Chertow GM, Leppert JT, Bhalla V. Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study. Hypertension 2020;75:650-9. [PMID: 32008436 DOI: 10.1161/HYPERTENSIONAHA.119.14359] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 12.5] [Reference Citation Analysis]
55 Huang C, Lee B, Liu K, Chang Y, Wu V, Lee P, Chang C. Preoperative non-stimulated adrenal venous sampling index for predicting outcomes of adrenalectomy for unilateral primary aldosteronism. Journal of the Formosan Medical Association 2020;119:1185-92. [DOI: 10.1016/j.jfma.2020.04.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Chang YH, Chung SD, Wu CH, Chueh JS, Chen L, Lin PC, Lin YH, Huang KH, Wu VC, Chu TS; TAIPAI Study Group. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism. Surgery 2020;167:367-77. [PMID: 31676114 DOI: 10.1016/j.surg.2019.08.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Huang WC, Chen YY, Lin YH, Chen L, Lin PC, Lin YF, Liu YC, Wu CH, Chueh JS, Chu TS, Wu KD, Huang CY, Wu VC; TAIPAI Study Group †., TAIPAI Study Group. Incidental Congestive Heart Failure in Patients With Aldosterone-Producing Adenomas. J Am Heart Assoc 2019;8:e012410. [PMID: 31801414 DOI: 10.1161/JAHA.119.012410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
58 Wachtel H, Fraker DL. Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism. Curr Cardiol Rep 2021;23:89. [PMID: 34081226 DOI: 10.1007/s11886-021-01516-0] [Reference Citation Analysis]
59 Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, Ito H, Tsuiki M, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T, Suzuki T, Naruse M. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism. Journal of Hypertension 2019;37:1513-20. [DOI: 10.1097/hjh.0000000000002070] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
60 Pillai PR, Griffith M, Schwarcz MD, Weiss IA. Primary Aldosteronism: Cardiovascular Risk, Diagnosis, and Management. Cardiol Rev 2020;28:84-91. [PMID: 31868768 DOI: 10.1097/CRD.0000000000000281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
61 Gunnarsdottir H, Jonsdottir G, Birgisson G, Gudmundsson J, Sigurjonsdottir HA. Are We Only Detecting the Tip of the Iceberg? A Nationwide Study on Primary Aldosteronism with up to 8-Year Follow-up. Endocr Res 2022;:1-9. [PMID: 35488403 DOI: 10.1080/07435800.2022.2068572] [Reference Citation Analysis]
62 Chen ZW, Pan CT, Tsai CH, Chang YY, Chang CC, Lee BC, Chiu YW, Huang WC, Lin YL, Wu VC, Hung CS, Liao CW, Lin YH, On Behalf Of Taipai Study Group. Heart-Ankle Pulse Wave Velocity Is Superior to Brachial-Ankle Pulse Wave Velocity in Detecting Aldosterone-Induced Arterial Stiffness. Biomedicines 2021;9:1285. [PMID: 34680402 DOI: 10.3390/biomedicines9101285] [Reference Citation Analysis]
63 Hellman P, Björklund P, Åkerström T. Aldosterone-Producing Adenomas. Vitam Horm 2019;109:407-31. [PMID: 30678866 DOI: 10.1016/bs.vh.2018.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
64 Wannachalee T, Turcu AF. Primary Aldosteronism: a Continuum from Normotension to Hypertension. Curr Cardiol Rep 2021;23:105. [PMID: 34196827 DOI: 10.1007/s11886-021-01538-8] [Reference Citation Analysis]
65 Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, Concistrè A, Del Pinto R, Fabris B, Fallo F, Fava C, Ferri C, Giacchetti G, Grassi G, Letizia C, Maccario M, Mallamaci F, Maiolino G, Manfellotto D, Minuz P, Monticone S, Morganti A, Muiesan ML, Mulatero P, Negro A, Parati G, Pengo MF, Petramala L, Pizzolo F, Rizzoni D, Rossitto G, Veglio F, Seccia TM. The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism. Int J Cardiol Hypertens 2020;5:100029. [PMID: 33447758 DOI: 10.1016/j.ijchy.2020.100029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
66 Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol 2020;16:578-89. [PMID: 32724183 DOI: 10.1038/s41574-020-0382-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]